Video Topic: Public Seminars
Patient Advocacy Day and Stem Cell Update – Concluding Remarks
(Part 7 of 7) Peter Donovan, director of UC-Irvine’s Sue and Bill Gross Stem Cell Research Center, gave the concluding remarks for “Synapses Firing: Connections Made”, a CIRM-hosted patient advocacy event. The 100+ people in attendance heard from patient advocates about living with neurodegenerative disease and from scientists about recent progress in stem cell research […]
Public Forum: A Dose of Reality on Alternative Stem Cell Treatments
A Dose of Reality on Alternative Stem Cell Treatments: What you don’t know can hurt you On June 15, 2010, the International Society for Stem Cell Research (ISSCR) in partnership with CIRM presented a public forum on the responsible path for delivering stem cell therapies to the clinic. The forum was moderated by Rachel Myrow, […]
Seminar Intro: Autism, Toxicology, Environmental Health and Stem Cell Science
Since World War II, over 80,000 chemical compounds have been developed in the U.S. About 3,000 of these chemicals are produced at rate of one million pounds per year. Do these chemicals have potential public health risks? Can exposure to these chemicals be linked to childhood development disorders, such as autism? What challenges do environmental […]
Eric Roberts: Pesticides and Autism
Since World War II, over 80,000 chemical compounds have been developed in the U.S. About 3,000 of these chemicals are produced at rate of one million pounds per year. Do these chemicals have potential public health risks? Can exposure to these chemicals be linked to childhood development disorders, such as autism? What challenges do environmental […]
Michael McMaster: Human Embryonic Stem Cells for Predictive Toxicology
Since World War II, over 80,000 chemical compounds have been developed in the U.S. About 3,000 of these chemicals are produced at rate of one million pounds per year. Do these chemicals have potential public health risks? Can exposure to these chemicals be linked to childhood development disorders, such as autism? What challenges do environmental […]
Tracy Woodruff: So Many Chemicals…So Little Time
Since World War II, over 80,000 chemical compounds have been developed in the U.S. About 3,000 of these chemicals are produced at rate of one million pounds per year. Do these chemicals have potential public health risks? Can exposure to these chemicals be linked to childhood development disorders, such as autism? What challenges do environmental […]
Blood cells from Embryonic Stem Cells: Cornelis Murre – CIRM Science Writer’s Seminar
Cornelis Murre, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Murre has a CIRM grant to develop an approach that would allow large-scale production of blood cells from human embryonic cells. Murre is a professor of biology at the University of California, San […]
Stem Cell-Derived Heart Cells: Bruce Conklin – CIRM Science Writer’s Seminar
(Part 3 of 9) Bruce Conklin, M.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Conklin has a CIRM grant to develop a method for screening drugs for toxic effects using stem cells. Conklin is a senior investigator at the Gladstone Institute of Cardiovascular […]
Fat-Derived Stem Cells for Tissue Repair: Michael Longaker – CIRM Science Writer’s Seminar
Michael Longaker, M.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Longaker has a CIRM grant to derive and analyze pluripotent disease specific stem cells that will provide a better understanding of cardiovascular and bone disease. Longaker is a Deane P. and Louise Mitchell […]
Stem Cell Based Diabetes Treatment: Alan Lewis – CIRM Science Writer’s Seminar
Alan Lewis, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis was president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Viacyte Inc. has four […]